Talphera’s Promising Prospects: Buy Rating Affirmed Amidst Strategic Advancements in Anticoagulant Development
Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...